Gene Query: ANXA1

Dataset Description Geneva Score
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 311.43
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 202.85
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 198.89
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 196.14
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 147.86
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 141.16
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 140.65
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 121.37
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 121.37
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq Human] 119.3
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 104.09
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 104.09
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 103.76
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 102.29
The cohesin release factor WAPL restricts chromatin loop extension. 102.02
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 102.02
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 96.21
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 96.21
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 93.99
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 87.51
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 86.87
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 84.65
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 83.38
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 81.99
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 81.63
AR-independent prostate cancer is sustained through FGF signaling 77.05
WRN knockout effects upon gene expression in SW48 and OVK18 76.1
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 75.55
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 75.53
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 75.46
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 72.74
RNA-Seq analysis of breast cancer cells after shikonin treatment 72.25
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 71.2
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 70.57
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 70.31
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 69.3
Knockdown of ADNP in HCT116 colon cancer cells 69.23
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 69.21
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 69.21
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 67.51
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 67.27
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 65.31
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 65.31
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 65.31
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 64.65
Transcriptomic analysis of human tonsillar TFH subsets 64.36
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 64.05
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 62.92
ARID1A regulates condensin II distribution and chromosomal partition 62.92
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 62.87
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 62.87
Lipid degradation promotes prostate cancer cell survival 62.39
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 61.78
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 60.86
Characterization of the Merkel cell carcinoma miRNome 60.81
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 59.97
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 58.7
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 58.53
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 58.05
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 58.05
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 56.82
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 56.13
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 56.13
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 55.41
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 55.2
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 54.76
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 54.68
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 54.28
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 54.03
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 54.03
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 52.99
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 52.53
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 52.25
DJ-1 is dispensable for human stem cell homeostasis 51.78
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 51.69
Effect of disulfiram treatment on pediatric high grade glioma 51.45
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 51.34
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 51.05
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 50.33
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 49.47
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 49.47
Transcriptome profiling of Normal and Cancerous Prostate Cells 48.91
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 48.87
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 48.76
Differential Gene Expression between MCF10A and MCF7 cells 48.05
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 47.92
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 47.32
Transcription control by the ENL YEATS domain in acute leukemia 47.32
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 46.8
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 46.65
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 46.46
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 46.39
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 46.39
A transcriptome-wide divergence in protein translation scales with LIN28B expression 46.25
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 46.14
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 46.12
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 46.03
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 46.0
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 45.94
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 45.91
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 45.82
Cerebellar differentiation in Ataxia-Telangiectasia 45.8
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 45.79
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 45.74
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 45.42
scRNASeq analysis of cycling cardiomyocytes 44.78
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 44.55
Differential gene expression profiles in imatinib-resistant cell lines 44.52
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 43.92
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 43.89
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 43.7
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 43.51
Uridylation by TUT4 and TUT7 marks mRNA for degradation 43.38
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 43.23
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 43.23
Exogenous rescue of KLHL9 in SF210 cell line 42.93
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 42.48
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 42.09
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 41.87
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 41.87
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 41.87
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 40.94
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 40.92
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 40.72
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 40.46
BI Human Reference Epigenome Mapping Project 40.42
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 40.32
DIGIT regulates endoderm differentiation of human embryonic stem cells 40.26
RNA-seq analysis of BAP1-depleted uveal melanoma cells 40.1
Cell responses to dysregulated VZV-induced cell-cell fusion 39.73
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 39.72
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 39.72
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 39.57
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 39.48
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 39.18
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 39.17
The MEF2B Regulatory Network 39.11
The MEF2B Regulatory Network - RNA-seq data 39.11
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 38.65
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 38.64
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 38.64
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 38.04
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 38.04
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 36.68
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 36.41
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 36.29
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 36.16
The effect of insulin on mRNA transcription of human pluripotent stem cells 36.11
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 36.09
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 36.09
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 36.01
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 35.99
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 35.85
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 35.33
Global transcriptome analysis of HAP1 cells 35.29
Evolution of a transcriptional regulator from a transmembrane nucleoporin 35.15
RNA-seq in HepG2 and IMR90 cells 35.15
RNA-seq analysis and shRNA screen of breast cancer 34.78
RNA-seq analysis of breast cancer 34.78
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 34.77
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 34.77
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 34.68
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 34.62
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 34.62
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 34.48
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 33.99
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 33.78
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 33.76
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 33.64
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 33.64
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 33.64
A prostate cancer chromatin interaction map 33.35
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 32.89
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 32.89
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 32.7
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 32.7
Accurate annotation of human protein-coding small open reading frames 32.56
PNET animal model: new insights (II) 32.54
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 32.47
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 32.38
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 32.31
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 31.54
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 31.25
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 30.99
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 30.99
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 30.92
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 30.92
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 30.86
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 30.49
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 30.44
CircRNAome diversity in human mature B-cells, T-cells and monocytes 30.41
The pause-initiation limit restricts transcription activation in human cells 30.28
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 30.27
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 30.22
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 30.12
MYCi975 regulates MYC target genes 30.11
Targeting MTHFD2 in Acute Myeloid Leukemia 30.0
The role of CFTR in islet function 29.94
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 29.88
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 29.69
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 29.68
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 29.58
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 29.58
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 29.57
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 29.5
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 29.38
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 29.33
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 29.3
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 29.17
BCL11B 28.85
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 28.72
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 28.65
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 28.64
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 28.59
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 28.59
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 28.48
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 28.41
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 28.39
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 28.29
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 28.27
RNA-Seq from early time points in the kidney differentiation protocol 28.25
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 28.21
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 28.21
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 28.19
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 28.19
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 27.99
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 27.85
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 27.85
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 27.66
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 27.37
Fusion discovery in breast cancer cell line 27.33
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 27.21
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 27.21
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 27.15
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 26.78
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 26.76
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 26.71
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 26.71
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 26.66
Lineage specific differentiation is influenced by state of human pluripotency 26.66
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 26.5
NHLRC1 re-expression in cancer cells 26.36
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 26.33
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 26.31
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 26.21
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 26.16
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 26.14
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 25.65
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 25.48
Crizotinib v. DMSO in SW480 cells 25.43
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 25.16
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 25.14
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 25.13
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 25.07
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 25.07
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 24.94
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 24.58
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 24.53
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 24.53
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 24.32
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 24.3
Total RNA sequencing of WT intestinal orgaonids. 24.23
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 24.22
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 24.2
Gene expression profile in breast cancer cell lines using RNA sequencing 24.18
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 24.15
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 23.81
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 23.61
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 23.44
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 23.32
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 23.26
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 23.1
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 23.04
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 23.04
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 22.98
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 22.92
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 22.86
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 22.86
miR941 overexpression experiment 22.74
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 22.62
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 22.62
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 22.58
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 22.58
mRNA expression in human DAOY cells 22.27
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 22.17
naive T cell heterogeneity after neonatal thymectomy 22.16
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 22.0
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 22.0
Identifying the molecular mode of action of itraconazole in colorectal cancer 21.98
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 21.95
Neonatal and adult human testis defined at the single-cell level 21.68
Transcriptome analysis of kidney organoids 21.5
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 21.41
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 21.39
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 21.06
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 21.01
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 21.01
Developmental stage specific chromosome architecture in human erythroid cells 20.98
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 20.98
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 20.69
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 20.69
iPSC-Derived Cholangiocytes 20.61
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 20.35
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 20.33
Primate transcript and protein expression levels evolve under compensatory selection pressures 20.27
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 20.04
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 20.03
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 20.03
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 19.83
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 19.78
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 19.78
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 19.58
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 19.07
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 19.07
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 18.98
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 18.98
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 18.92
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 18.84
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 18.68
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 18.59
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 18.51
RNA-seq analysis of RALD iPSCs after in vitro differentiation 18.5
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 18.44
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 18.29
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 18.21
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 18.16
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 18.16
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 18.13
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 18.1
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 17.82
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 17.61
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 17.52
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 17.49
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 17.1
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 16.82
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 16.63
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 16.29
High-efficiency RNA-based reprogramming of human primary fibroblasts 15.94
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 15.59
The Glioma-Infiltrating T Cell Receptor Repertoire 15.3
Gene profiling of human adult and pediatric liver cancer cells 15.26
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 15.2
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 15.2
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 15.03
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 14.98
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 14.32
Recovery and analysis of nascent RNA 14.32
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 14.12
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 14.1
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 14.1
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 14.1
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 14.09
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 13.94
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 13.92
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 13.62
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 13.61
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 13.4
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 13.4
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 13.4
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 13.15
RNA-seq analysis of uveal melanoma cells treated with FR900359 13.07
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 13.04
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 13.02
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 12.96
Functional astrocytes differentiated from hiPSCs 12.93
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 12.51
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 12.5
Human cells contain natural double-stranded RNAs with potential regulatory capacity 12.43
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 12.39
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 12.29
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 12.24
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 12.1
RNA seq analysis of human Fetal and adult derived Enterospheres 11.71
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 11.51
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 10.85
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 10.85
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 10.76
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 10.73
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 10.72
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 10.68
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 10.67
Activity-dependent transcriptional changes in human neurons 10.25
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 10.2
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 10.2
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 10.16
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 10.13
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 10.13
Regulatory network controlling tumor-promoting inflammation in human cancers 10.0
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 10.0
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 9.94
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 9.93
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 9.93
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 9.89
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 9.75
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 9.55
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 9.38
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 9.17
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 9.12
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 8.93
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 8.93
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 8.92
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 8.83
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 8.7
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 8.66
A novel target of EZH1/2 for treatment of mantle cell lymphoma 8.45
RNAseq of T-ALL upon long non coding rna purturbation 8.38
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 8.14
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 8.03
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 8.03
Zika virus directly infects human peripheral neurons and induces cell death 8.03
SLAM-seq for K562 endogenous mRNA decay 8.0
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 7.92
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 7.87
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 7.84
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 7.74
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 7.65
RNA-Seq of the corpus callosum from 12 individuals 7.58
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 7.5
Expression profiles of the four human major ectodermal lineages 7.39
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 7.38
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 7.23
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 6.98
TAF1 is critical for AE driven leukemogenesis 6.9
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 6.9
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 6.86
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 6.78
Differences in miRNA Detection Levels are Technology and Sequence Dependent 6.78
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 6.75
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 6.73
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 6.61
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 6.38
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 6.34
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 6.08
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 6.0
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 5.91
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 5.81
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 5.78
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 5.71
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 5.53
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 5.42
PRDM1 inhibits proliferation of human colon cancer organoids 5.14
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 4.86
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 4.84
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 4.73
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 4.57
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 4.51
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 4.27
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 4.09
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 4.07
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 4.05
WNT signaling memory is required for ACTIVIN to function as a morphogen 4.05
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 4.0
Human Treg IFNg/IL-10 subpopulations 3.89
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 3.8
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 3.76
RNA sequencing of T-ALL (COG study) 3.61
Analyses of T-ALL (COG study) 3.61
Gene expression alterations of pancreatic intraepithlial neoplasia 3.45
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 3.39
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 3.32
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 3.28
MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma 3.23
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 3.21
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 3.19
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 3.09
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 3.04
N6-methyladenine DNA Modification in Glioblastoma 2.99
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 2.99
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 2.84
Ribosomal protein RPL26 is the principal target of UFMylation 2.8
RNA-seq of IL-4 stimulated human keratinocytes 2.45
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 2.05
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 2.05
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 1.93
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 1.86
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 1.57
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 1.5
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 1.47
Changes in human endometrial gland transcriptome over the window of implantation 1.46
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 1.45
Dynamic 3D chromosomal landscapes in acute leukemia 1.27
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 1.27
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 1.16
Role of cervicovaginal microbiota in genital inflammation 1.16
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 1.05
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 1.05
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 1.05
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.92
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 0.91
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 0.83
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 0.76
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.74
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 0.72
BET bromodomain inhibition 0.72
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 0.65
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 0.65
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 0.48
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 0.44
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 0.18
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation